首页> 外文期刊>Diabetes >Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor.
【24h】

Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor.

机译:缺乏雄激素受体的小鼠对高瘦素血症的胰岛素和瘦素抵抗。

获取原文
获取原文并翻译 | 示例
       

摘要

Epidemiological evidence suggests that sex differences exist in type 2 diabetes. Men seem to be more susceptible than women to the consequences of obesity and sedentary lifestyle, possibly because of differences in insulin sensitivity and regional body fat deposition. Thus, lacking androgen receptor (AR) in male individuals may promote insulin resistance. To determine whether lacking AR in male individuals contributes to in vivo insulin resistance, an AR knockout model (AR(-/y)) was used to study the correlation between AR and insulin resistance. Progressive reduced insulin sensitivity and impaired glucose tolerance were seen in AR(-/y) mice with advancing age. Aging AR(-/y) mice displayed accelerated weight gain, hyperinsulinemia, and hyperglycemia, and loss of AR contributes to increased triglyceride content in skeletal muscle and liver. Leptin is higher in serum of AR(-/y) mice. Treatment with exogenous leptin fails to stimulate weight loss in AR(-/y) mice in advanced age, suggesting leptin resistance in the AR(-/y/) mice. Exogenous dihydrotestosterone replacement fails to reverse the metabolic abnormalities and insulin resistance in AR(-/y) mice. Our in vivo studies demonstrate that androgen-AR plays key roles in the development of insulin and leptin resistance, which may contribute to the development of type 2 diabetes and cardiovascular disease.
机译:流行病学证据表明,在2型糖尿病中存在性别差异。男人似乎比女人更容易肥胖和久坐的生活方式,这可能是由于胰岛素敏感性和局部脂肪沉积的差异所致。因此,男性缺乏雄激素受体(AR)可能会促进胰岛素抵抗。为了确定男性个体中缺乏AR是否会导致体内胰岛素抵抗,AR基因敲除模型(AR(-/ y))用于研究AR与胰岛素抵抗之间的相关性。随着年龄的增长,在AR(-/ y)小鼠中观察到胰岛素敏感性逐渐降低和葡萄糖耐量降低。衰老的AR(-/ y)小鼠表现出加速的体重增加,高胰岛素血症和高血糖症,而AR的丧失则有助于骨骼肌和肝脏中甘油三酸酯含量的增加。瘦素在AR(-/ y)小鼠的血清中较高。用外源瘦素治疗无法刺激高龄AR(-/ y)小鼠体重减轻,表明AR(-/ y /)小鼠中瘦蛋白抵抗。外源性二氢睾丸激素替代不能逆转AR(-/ y)小鼠的代谢异常和胰岛素抵抗。我们的体内研究表明,雄激素-AR在胰岛素和瘦素抵抗的发展中起关键作用,这可能有助于2型糖尿病和心血管疾病的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号